325 related articles for article (PubMed ID: 21751366)
1. Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells.
Ali NA; Molloy MP
Proteomics; 2011 Aug; 11(16):3390-401. PubMed ID: 21751366
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells.
Ali NA; McKay MJ; Molloy MP
Mol Biosyst; 2010 Nov; 6(11):2332-8. PubMed ID: 20862427
[TBL] [Abstract][Full Text] [Related]
3. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
[TBL] [Abstract][Full Text] [Related]
4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
Muñoz J; Heck AJ
Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
[TBL] [Abstract][Full Text] [Related]
6. Quantitative phosphoproteomics studies using stable isotope dimethyl labeling coupled with IMAC-HILIC-nanoLC-MS/MS for estrogen-induced transcriptional regulation.
Wu CJ; Chen YW; Tai JH; Chen SH
J Proteome Res; 2011 Mar; 10(3):1088-97. PubMed ID: 21210654
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive phosphoproteome analysis of INS-1 pancreatic β-cells using various digestion strategies coupled with liquid chromatography-tandem mass spectrometry.
Han D; Moon S; Kim Y; Ho WK; Kim K; Kang Y; Jun H; Kim Y
J Proteome Res; 2012 Apr; 11(4):2206-23. PubMed ID: 22276854
[TBL] [Abstract][Full Text] [Related]
8. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
Zhang Y; Feng X; We R; Derynck R
Nature; 1996 Sep; 383(6596):168-72. PubMed ID: 8774881
[TBL] [Abstract][Full Text] [Related]
9. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
10. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
13. SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells.
Pohl M; Radacz Y; Pawlik N; Schoeneck A; Baldus SE; Munding J; Schmiegel W; Schwarte-Waldhoff I; Reinacher-Schick A
Anticancer Res; 2010 Jul; 30(7):2603-13. PubMed ID: 20682989
[TBL] [Abstract][Full Text] [Related]
14. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
Yang F; Stenoien DL; Strittmatter EF; Wang J; Ding L; Lipton MS; Monroe ME; Nicora CD; Gristenko MA; Tang K; Fang R; Adkins JN; Camp DG; Chen DJ; Smith RD
J Proteome Res; 2006 May; 5(5):1252-60. PubMed ID: 16674116
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
20. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]